Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-25-000117
Filing Date
2025-08-14
Accepted
2025-08-14 16:58:26
Documents
1
Period of Report
2025-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1755205102.html 4  
1 FORM 4 wk-form4_1755205102.xml 4 3826
  Complete submission text file 0001824293-25-000117.txt   5511
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Rongen Roelof (Reporting) CIK: 0001698966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 251220610

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Issuer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)